Michelle T. Long

International Medical Vice President, NASH & Liver Diseases, Novo Nordisk, Denmark
When
2nd-3rd Mar 2023
Where
London, UK
London Heathrow Marriott Hotel
“On behalf of the team at Global Engage and our expert speaker panel, I look forward to welcoming you to the 6th Global NASH Congress – a live and in-person meeting!”
Steve Hambrook, CEO
NASH continues to be a huge unmet clinical need globally, and although no therapy has received regulatory approval, there continues to be research advancing our understanding of the disease’s mechanisms. Developments in non-invasive diagnostic biomarkers continue to offer the hope that they will replace liver biopsies and there have been improvements to in vivo liver models. All these are the focus of this year’s congress as well as new preclinical and clinical research. The most promising therapeutics in development and business case studies will also be featured at this meeting.
NEW FOR 2023
“I really enjoyed the scientific content of the conference with news from
providers and Pharma organisations.” Delegate Pharma Company
“There was a good variety of speakers & content with ample networking
opportunities” NHS Delegate
“A very good spread of content with topics that were applicable to a wide
audience.” Academic delegate
“Well organised, varied content covering the main aspects of NASH and drug
development.” Speaker
“I appreciated the broad spectrum of areas within NASH from clinical trials and
biomarker to scientific new projects. The conference provided a nice overview of
the field as of today.” Sponsor
Featured 2023 Speakers – see the full panel
Senior Director, Global Regulatory Affairs, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Sweden
Executive Director & Clinical Pathology Lead, Merck Sharp Dohme
Chief Medical Officer, Inventiva, USA, France
Associate Professor, Karolinska Institutet, Sweden
Assistant Professor, Boston University, USA
Executive Director Hepatology and Speciality Medicines, Advanz Pharma, France
Head of Research, Inselspital, University Hospital Bern, Switzerland
CEO, CureDiab Metabolic Research GmbH, Germany
Senior Corporate Clinical Program Leader, Boehringer Ingelheim
Chief Medical Officer, Altimmune, USA
Venture Partner, Apollo Health Ventures, USA
Clinical Research Fellow/PhD Student,
Oxford Centre for Diabetes, Endocrinology and Metabolism, UK
Postdoctoral Scientist, The Roger WiIliams Institute of Hepatology, UK
Executive Director of Clinical and Preclinical Pharmacology, Galectin Therapeutics, USA
Senior AI Lead, Tribun Health
Vice President, Pharma Echosens, France
Chief Development Officer, Terns Pharmaceuticals
Director of Research, Penn State Liver Center, USA
Honorary Clinical Fellow, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford University Hospital NHS England, UK
Chief Medical Officer, Madrigal Pharmaceuticals, USA
Scientific Officer, Julius Clinical
Associate Professor, University of Westminster, UK
Chief Medical officer, SomaLogic, USA
Chief Medical Officer, Altimmune
MD, FACC, Executive Director, Cardiac Safety Research Consortium, USA
Senior Research Fellow, University of Oxford, UK
Merinoff Endowed Chair, Professor of Medicine, Co-Director, Institute for Bioelectronic Medicine Feinstein Institutes for Medical Research & Cold Spring Harbor Laboratory
Chief Medical Officer, Hepion Pharmaceuticals Inc
Vice-President, Liver Health Programs, Global Liver Institute
Postdoctoral Researcher, Ghent University, Belgium
International Medical Vice President, NASH & Liver Diseases, Novo Nordisk, Denmark
Professor, University of Southampton, England
Senior Researcher, Biomedical Research Institute of Murcia (IMIB)
Professor, German Cancer Research Center (DKFZ), Heidelberg and Director, The M3 Research Institute, Tuebingen, Germany
Director, UNC Liver Center, University of North Carolina, USA
Fondazione Policlinico Gemelli IRCCS, Catholic University of Rome
Associate Professor, University of Southern Denmark, Denmark
Industrial Research Fellow, Nordic Bioscience
Senior Director, Global Regulatory Affairs, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Sweden
Executive Director & Clinical Pathology Lead, Merck Sharp Dohme
Chief Medical Officer, Inventiva, USA, France
Associate Professor, Karolinska Institutet, Sweden
Assistant Professor, Boston University, USA
Executive Director Hepatology and Speciality Medicines, Advanz Pharma, France
Head of Research, Inselspital, University Hospital Bern, Switzerland
CEO, CureDiab Metabolic Research GmbH, Germany
Senior Corporate Clinical Program Leader, Boehringer Ingelheim
Chief Medical Officer, Altimmune, USA
Venture Partner, Apollo Health Ventures, USA
Clinical Research Fellow/PhD Student,
Oxford Centre for Diabetes, Endocrinology and Metabolism, UK
Postdoctoral Scientist, The Roger WiIliams Institute of Hepatology, UK
Executive Director of Clinical and Preclinical Pharmacology, Galectin Therapeutics, USA
Senior AI Lead, Tribun Health
Vice President, Pharma Echosens, France
Chief Development Officer, Terns Pharmaceuticals
Director of Research, Penn State Liver Center, USA
Honorary Clinical Fellow, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford University Hospital NHS England, UK
Chief Medical Officer, Madrigal Pharmaceuticals, USA
Scientific Officer, Julius Clinical
Associate Professor, University of Westminster, UK
Chief Medical officer, SomaLogic, USA
Chief Medical Officer, Altimmune
MD, FACC, Executive Director, Cardiac Safety Research Consortium, USA
Senior Research Fellow, University of Oxford, UK
Merinoff Endowed Chair, Professor of Medicine, Co-Director, Institute for Bioelectronic Medicine Feinstein Institutes for Medical Research & Cold Spring Harbor Laboratory
Chief Medical Officer, Hepion Pharmaceuticals Inc
Vice-President, Liver Health Programs, Global Liver Institute
Postdoctoral Researcher, Ghent University, Belgium
International Medical Vice President, NASH & Liver Diseases, Novo Nordisk, Denmark
Professor, University of Southampton, England
Senior Researcher, Biomedical Research Institute of Murcia (IMIB)
Professor, German Cancer Research Center (DKFZ), Heidelberg and Director, The M3 Research Institute, Tuebingen, Germany
Director, UNC Liver Center, University of North Carolina, USA
Fondazione Policlinico Gemelli IRCCS, Catholic University of Rome
Associate Professor, University of Southern Denmark, Denmark
Industrial Research Fellow, Nordic Bioscience
Please contact [email protected] for more information about speaking
opportunities.
The Agenda in brief
What’s included
All conference sessions
Lunches and refreshments
Access to exhibition room
All networking forums
e-documentation pack
3 for the price of 2 offer
5 pass discounted price £360/£700 per person Academic/Industry
Discount applied automatically when registering places at once. If you do not know all the attendees complete this form
Not applicable for solution provider companies or compatible with any other offers or discount codes
Option 1 – Please phone +44 (0) 1865 671957 ext. 207 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
£1,099.00
Standard registration for those not in the categories below
£599.00
Entrance Fee for Academic / Non-for-Profit Organisation (USD)
£1,299.00
Fee for representatives of organisations offering services and/or business & technology solutions and also to business consultants.
Poster presentation sessions will take place in breaks and alongside the other breakout sessions of the conference. Your presentation will be displayed in a dedicated area, with the other accepted posters from industry and academic presenters.
We also issue a poster eBook to all attendees containing your full abstract, and you can share your poster as a PDF after the meeting if you desire (optional).
Whether looking for funding, employment opportunities or simply wanting to share your work with a like-minded and focused group, these are an excellent way to join the heart of this congress.
In order to present a poster at the congress, you must be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first come first served basis (subject to checks and successful registration).
SUBMISSION INSTRUCTIONS
We will require the form (downloadable below) to be submitted by 10th February 2023. This is the formal deadline however space is another limiting factor so early application is recommended. Therefore please contact us with any questions you have as soon as possible.
POSTER COMPETITION – CLOSING DATE 10th February 2023
1. Submit your entry prior to the closing deadline (1 entry per person)
2. Two entries for the 6th Global NASH Congress will be selected by the judges
3. The winner of the poster presentation will be given a 15-minute speaking position on the conference agenda and will be notified in advance of the meeting
4. The judge(s) will make the decision based on the abstract(s) submitted
5. The winner will also receive a certificate from the organisers
6. Representatives from solution provider organisations or experts already speaking on the program are not eligible to enter the competition but are welcome to present posters at the meeting as normal
SomaLogic is fostering the discovery of effective and safer treatments for patients while empowering more accurate diagnosis, prevention, and treatment of disease through the next generation of proteomics.
×
A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health recognized worldwide with more than 3,500+ peer-reviewed publications and 160+ international guidelines.
Echosens solutions support drug development: accelerating recruitment, optimizing cost-effectiveness, de-risking execution and preparing for commercialization with a strong expertise and already a presence in over 100+ countries enabling millions of liver examinations worldwide.
×WCG delivers transformational solutions that achieve quality outcomes and maximize efficiency in Endpoint Adjudication and Data Monitoring Committees. WCG is proud to support the industry’s top ongoing clinical trials in the NASH space by helping to lower the risk of variation and reduce inconsistencies or bias in clinical trial data to the regulatory agencies.
×
Tribun Health is acting in favor of precision medicine for faster and more accurate diagnosis and patient segmentation. The company is a pioneer in digital pathology workflow solutions with a web-based IMS, image analysis using AI-powered deep and machine learning algorithms, remote case sharing, reporting and GCP/GLP translational and clinical central imaging platform. These platforms, combined with AI expertise helps biopharma clients to optimize drug development process, fine-tune patient segmentation and de-risk clinical studies.
https://www.tribun.health/pharma-solutions
×Julius Clinical is a global Academic CRO with a distinct focus on unmet medical needs. Our scientific expertise combined with creative operational solutions uniquely equips us to assist in providing answers for today’s clinical drug development challenges. As a response to the NASH conundrum, we initiated: GRIP ON NASH, a multinational research initiative in which 10,000 patients at risk will be screened for the presence of NAFLD and NASH.
https://www.juliusclinical.com/areas-of-expertise/nonalcoholic-steatohepatitis/
Accelerated Enrollment Solutions (AES) helps biopharmaceutical companies overcome patient enrollment and research site challenges by combining a powerful patient recruiting solution with more than 160 clinical research sites located throughout the world. As a business of PPD, part of Thermo Fisher Scientific, we are committed to optimizing each step in the patient journey and delivering best-in-class site performance to bring our customers greater certainty to clinical trial delivery.
×Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time.
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and/or increase brand awareness by taking a poster position or sponsoring the poster sessions. This can be supplemented by branding options such as placing your logo on the meeting background screen.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas where all refreshment breaks and lunches take place, as well as the networking drinks reception.
Options include:
For further details please contact Gavin Hambrook +44 (0) 7538368764 and Reuben Raj +603 2731 9335 will be happy to discuss how you can be a part of the meeting.
To improve the lives of individuals and families impacted by liver disease through promoting innovation, encouraging collaboration, and scaling optimal approaches to help eradicate liver diseases.
×ELPA is an umbrella association based in Brussels, representing 32 members from 25 countries. It is also the biggest European association representing advocating for liver patients’ voices and unmet needs for more than 15 years.
Our aim is to promote the interests of people with liver disease and in particular: to highlight the size of the problem; to promote awareness and prevention; to address the low profile of liver disease as compared to other areas of medicine such as heart disease; to share the experience of successful initiatives; to work with professional bodies such as EASL and with the EU to ensure that treatment and care are harmonized across Europe to the highest standards. ELPA is also involved in 10 European projects playing a crucial role in the field of dissemination and communication.
We raise awareness and educate Canadians about the risks, causes and complications of fatty liver disease and help those already diagnosed with nonalcoholic fatty liver disease (NAFLD), metabolic associated fatty liver disease (MAFLD) and nonalcoholic steatohepatitis (NASH) by advocating for access to approved treatments and care.
https://www.fattyliver.ca/
Hep magazine and HepMag.com are the go-to sources for educational and social support for people living with liver diseases like hepatitis C, hepatitis B, hepatitis A and NASH. Launched in 2010, the website is devoted to combating the stigma and isolation surrounding liver diseases and offers news, in-depth reporting, educational tools, care resources, and peer-to-peer networking.
×Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical Industry, keeping a tab on the updated and latest updates and trends concerning the field.
×Clocate.com is a leading international directory for worldwide conferences and exhibitions. Clocate.com is equipped with a unique and comprehensive search that helps you find easily any event in any category or location. Each event includes detailed information, like, description, dates, location, map, prices, link to the event’s website and more…
If you search for a conference or exhibition in areas such as Industry and manufacturing, Health and medicine, Technology and IT, Business and finance, sciences, education, services (banking, insurance, tourism, Hospitality and more), government, environment, life style and arts, you’ll find it in Clocate.com.
Global Engage is a member of ISLA, a body established to accelerate the event industry transition to a sustainable future. As part of this, we are committed to selecting venues with more sustainable practices.
You can read the London Heathrow Marriott’s environmental goals here.
The London Heathrow Marriott Hotel is:
We have reduced waste by replacing printed documentation with an app. Make sure you have it downloaded to your devices in time for the meeting. Get Agorify on Google Play and Apple App Store.
You will have some great food choices while you are with us but now we have worked with the caterer to increase the proportion of plant-based items. We have also built a plan with the venue to avoid waste through how they serve meals and how any leftovers are processed. Our aim is that you have some great meals, whilst with us, but with less environmental impact by the time you leave.
An international meeting does involve travel but where it is practical, please consider more sustainable alternatives to flying. The app will also have a discussion space to arrange ride shares.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.